Altitude Lab will relocate its accelerator and startup community to Portal Innovations at Woodbine Labs, combining Utah's established biotech accelerator with new laboratory infrastructure, graduate ...
Recursion Pharmaceuticals RXRX reported a loss of 22 cents per share in the third quarter of 2026, narrower than the Zacks ...
Recursion Pharmaceuticals (NASDAQ:RXRX) reported updated clinical data for its investigational treatment for familial ...
Together AI builds an agentic compiler to try and bring recursive self improvement capabilities to open source models.
Portal Innovations, a venture development platform supporting early-stage life sciences companies, today announced a strategic partnership with Altitude Lab to strengthen the resources available to ...
Box ManipulationIn the history of artificial intelligence and machine learning, the determination of internal parameters ...
Recursion said it expects to launch its first registrational trial in the second half of this year for its lead candidate REC-4881 based on talks with the FDA, after the oral familial adenomatous ...
Recursion Q3 2026 earnings: clinical wins for REC-4881 and REC-1245, Sanofi progress, and cash runway to 2029.
The generosity of strangers has long powered online communities. Spaces like Stack Overflow, GitHub, curl, OpenSSL, Wikipedia ...
A $10 million Sanofi milestone drove revenue 258% higher year over year, beating expectations and showing the AI platform ...
A Google DeepMind and Stanford study finds simple shapes like a red heart can push AI models such as GPT-5.4 and Claude ...
On November 2, 2026, four researchers including Rikiya Takehi from MIT CSAIL (Computer Science and Artificial Intelligence ...